omeprazole sulfone has been researched along with mephenytoin in 4 studies
Studies (omeprazole sulfone) | Trials (omeprazole sulfone) | Recent Studies (post-2010) (omeprazole sulfone) | Studies (mephenytoin) | Trials (mephenytoin) | Recent Studies (post-2010) (mephenytoin) |
---|---|---|---|---|---|
50 | 12 | 17 | 580 | 35 | 32 |
Protein | Taxonomy | omeprazole sulfone (IC50) | mephenytoin (IC50) |
---|---|---|---|
Cytochrome P450 2C19 | Homo sapiens (human) | 1.185 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chiba, K; Ishizaki, T; Kobayashi, K; Lee, KH; Shin, SG; Sohn, DR | 1 |
Brockmöller, J; Esdorn, F; Roots, I; Rost, KL | 1 |
He, N; Huang, SL; Shu, Y; Wang, LS; Wang, W; Xiao, WM; Xu, ZH; Zhou, HH | 1 |
Chow, AH; Chow, MS; Tomlinson, B; Waye, MM; Yin, OQ | 1 |
1 trial(s) available for omeprazole sulfone and mephenytoin
Article | Year |
---|---|
Omeprazole as a CYP2C19 marker in Chinese subjects: assessment of its gene-dose effect and intrasubject variability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Asian People; Cross-Over Studies; Cytochrome P-450 CYP2C19; Enzyme Inhibitors; Gene Dosage; Humans; Hydroxylation; Male; Mephenytoin; Mixed Function Oxygenases; Omeprazole; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Reference Values | 2004 |
3 other study(ies) available for omeprazole sulfone and mephenytoin
Article | Year |
---|---|
Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4'-hydroxylation recruited from an Oriental population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Humans; Hydroxylation; Korea; Male; Mephenytoin; Omeprazole | 1992 |
Phenocopies of poor metabolizers of omeprazole caused by liver disease and drug treatment.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Ulcer Agents; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Genotype; Humans; Liver Diseases; Male; Mephenytoin; Middle Aged; Mixed Function Oxygenases; Omeprazole; Peptic Ulcer; Phenotype; Polymorphism, Genetic | 1995 |
5-hydroxylation of omeprazole by human liver microsomal fractions from Chinese populations related to CYP2C19 gene dose and individual ethnicity.
Topics: Adult; Antibodies, Monoclonal; Aryl Hydrocarbon Hydroxylases; China; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Ethnicity; Gene Dosage; Genotype; Humans; Hydroxylation; Mephenytoin; Microsomes, Liver; Mixed Function Oxygenases; Omeprazole; Substrate Specificity; Troleandomycin | 2000 |